COMPASS Pathways Operating Expenses 2019-2025 | CMPS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

COMPASS Pathways operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

COMPASS Pathways operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151B
CVS Health (CVS)	$87B
Elevance Health (ELV)	$69.7B
Cencora (COR)	$56.8B
DiDi Global (DIDIY)	$25.8B
Labcorp Holdings (LH)	$22.5B
Natera (NTRA)	$22.4B
BioMerieux (BMXMF)	$17.2B
EUROFINS SCIENT (ERFSF)	$15.6B
ICON (ICLR)	$14.2B
CochLear (CHEOY)	$13.4B
Medpace Holdings (MEDP)	$12.9B
Solventum (SOLV)	$12.4B
Viatris (VTRS)	$12.4B
Revvity (RVTY)	$10.5B
Caris Life Sciences,�Inc (CAI)	$10.3B
Sonic Healthcare (SKHHY)	$9.1B
Avantor (AVTR)	$8.8B
HealthEquity (HQY)	$7.8B
Charles River Laboratories (CRL)	$7.7B
Bausch + Lomb (BLCO)	$5.2B
Sotera Health (SHC)	$4.5B
BrightSpring Health Services (BTSG)	$4B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.6B
Alignment Healthcare (ALHC)	$3B
Concentras Parent (CON)	$3B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.5B
Premier (PINC)	$2.1B